<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200315046784N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-10-06</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Effectiveness of knee external support (knee orthosis and or kinesiotape) on knee osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of knee orthosis versus Kinesio tape on pain, physical function, strength and proprioception in patients with  knee osteoarthritis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-10-13</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>56</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59032</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The group allocation will be performed through permuted block randomization  at an assignment ratio of 1:1. For allocation concealment, the randomization codes will be kept in opaque, sealed, sequentially numbered envelopes.
Sample size is estimated at 50, however, to take account of potential withdrawals, 56 patients (n=28 per group) will be recruited for the study. First, create and seal 28 treatment A envelopes and 28 treatment B envelopes. To create a block of 4, we will select 2 treatment A envelopes and 2 treatment B envelopes. We will shuffle these 4 envelopes thoroughly, and place this block of 4 in a separate pile. Then, we will prepare additional blocks of 4 until all 28 treatment A and B envelopes have been used. All additional blocks will be placed in their own individual piles. We will have 14 individual piles of shuffled blocks of 4, for example AABB, BBAA, ABBA, BAAB, ABAB, BABA, Blinding description: The outcome assessor will be blinded to group allocation, because all dependent variables will be measured without the orthosis and or tape, and the patients will remove their knee orthosis or kinesio-taping before referring for post-intervention assessment. Furthermore, all data will be encoded to prevent bias and to blind the statistician.</study_design>
      <phase>N/A</phase>
      <hc_freetext>knee osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: knee orthosis: Knee orthosis is made from an elastic/neoprene material and have lateral stays for more support. The patients will be asked to wear the knee orthosis all day long for 4 weeks. Intervention 2: Intervention group: kinesiotape: three ‘‘I’’ strips will be taken and applied with a 50% to 75% tension. The base of the first strip will be applied 10 cm below the anterior superior iliac spine, and will be pulled along the course of the rectus femoris until the superior border of the patella. The base of the second ‘‘I’’ strip will be applied below the greater trochanter and the tape will be pulled along the course of the vastus lateralis until the lateral border of the patella. The base of the third strip will be applied from the middle 1/3 of the medial aspect of the thigh. The tape will be pulled along the course of vastus medialis towards the medial border of the patella. Kinesio tape will be applied once a week for 4 weeks, with 2 day off for the skin rest between applications.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Azadinia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahnazari st., Mother Sq., Mirdamad Blvd</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>azadinia.fatemeh@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Azadinia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahnazari st., Mother sq., Mirdamad Blvd</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>azadinia.fatemeh@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>pain intensity of at least 4
Kellgren and Lawrence grade 2 or 3
the American College of Rheumatology classification criteria
standing and walking without assistance
age ranging from 50 to 65 years</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>knee flexion contracture
corticosteroid injection within the past 6 month
neurological diseases
systemic diseases
BMI of more than 36
diabetes mellitus
history of wearing knee orthoses or applying Kinesio-tape for the last 6 months
Patellofemoral pain syndrome
Hip and knee replacement</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: knee orthosis: Knee orthosis is made from an elastic/neoprene material and have lateral stays for more support. The patients will be asked to wear the knee orthosis all day long for 4 weeks.</i_keyword>
      <i_keyword>Intervention group: kinesiotape: three ‘‘I’’ strips will be taken and applied with a 50% to 75% tension. The base of the first strip will be applied 10 cm below the anterior superior iliac spine, and will be pulled along the course of the rectus femoris until the superior border of the patella. The base of the second ‘‘I’’ strip will be applied below the greater trochanter and the tape will be pulled along the course of the vastus lateralis until the lateral border of the patella. The base of the third strip will be applied from the middle 1/3 of the medial aspect of the thigh. The tape will be pulled along the course of vastus medialis towards the medial border of the patella. Kinesio tape will be applied once a week for 4 weeks, with 2 day off for the skin rest between applications.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: pre-intervention, and after 4-weeks intervention. Method of measurement: Visual Analogue Scale (VAS).</prim_outcome>
      <prim_outcome>WOMAC index. Timepoint: pre-intervention, and after 4-weeks intervention. Method of measurement: overall WOMAC score.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Position sense error. Timepoint: Pre-intervention, and after 4 weeks intervention. Method of measurement: Isokinetic Machine.</sec_outcome>
      <sec_outcome>Threshold to detection of passive motion. Timepoint: pre-intervention, after 4-weeks intervention. Method of measurement: Isokinetic Machine.</sec_outcome>
      <sec_outcome>Force sense. Timepoint: Pre-intervention, and after 4-weeks intervention. Method of measurement: Isokinetic Machine.</sec_outcome>
      <sec_outcome>Quadriceps strength. Timepoint: Pre-intervention, and after 4-weeks intervention. Method of measurement: Isokinetic machine.</sec_outcome>
      <sec_outcome>Timed Up and Go. Timepoint: Pre-intervention and after 4-weeks intervention. Method of measurement: time via chronometer.</sec_outcome>
      <sec_outcome>One leg stance. Timepoint: pre-intervention, and after 4-weeks intervention. Method of measurement: time via chronometer.</sec_outcome>
      <sec_outcome>Balance index. Timepoint: pre-intervention, and after 4-weeks intervention. Method of measurement: Biodex Balance system.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-01-31</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Shahid Hemmat Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
